Advisors Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,716
Closed -$222K 1452
2025
Q3
$222K Sell
4,716
-73
-2% -$3.79K ﹤0.01% 1106
2025
Q2
$249K Sell
4,789
-163
-3% -$8.95K ﹤0.01% 1082
2025
Q1
$299K Sell
4,952
-103
-2% -$6.64K 0.01% 1046
2024
Q4
$346K Sell
5,055
-45
-0.9% -$3.14K 0.01% 1011
2024
Q3
$367K Sell
5,100
-107
-2% -$7.55K 0.01% 999
2024
Q2
$361K Buy
5,207
+921
+21% +$67.2K 0.01% 975
2024
Q1
$343K Buy
4,286
+2,135
+99% +$190K 0.01% 1017
2023
Q4
$236K Buy
+2,151
New +$222K ﹤0.01% 1085
2021
Q2
Sell
-160
Closed -$21K 1421
2021
Q1
$21K Sell
160
-15
-9% -$1.8K ﹤0.01% 1458
2020
Q4
$20K Sell
175
-1
-0.6% -$95 ﹤0.01% 1473
2020
Q3
$14K Sell
176
-7
-4% -$571 ﹤0.01% 1475
2020
Q2
$13K Buy
183
+45
+33% +$3.13K ﹤0.01% 1483
2020
Q1
$8K Buy
+138
New +$12.7K ﹤0.01% 1429

Other funds holding CNMD

Advisors Asset Management's CNMD Position: Q4 2025 in Review

Advisors Asset Management sold out of CONMED (CNMD) in Q4 2025, closing a stake of 4,716 shares — an estimated $222K sold.

Advisors Asset Management first reported a position in CNMD in Q1 2020 and held it in 13 quarters. The position peaked at $367K in Q3 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Advisors Asset Management reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Advisors Asset Management sold 4,716 CONMED shares in Q4 2025, an estimated $222K.
  • Advisors Asset Management first reported a position in CONMED in Q1 2020 and held it in 13 quarters.
  • Advisors Asset Management's CONMED position peaked at $367K in Q3 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Advisors Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.